# US 2012/0232262 A1 · Method for preparing n-succinimidyl n-biotinyl-6-aminocaproate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232262 A1
- Document ID: US20120232262A1
- Status: Published application
- Kind: A1
- Application number: 13/510,900
- Filed: 2010-11-19
- Published: 2012-09-13
- Earliest claimed: 2009-11-20
- Assignees: Sanofi
- Inventors: Pierre Potier; Raphael Sole; Patrick Trouilleux
- Web page: https://patentgrep.com/patent/US20120232262A1

## CPC

- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to a method for preparing N-succinimidyl N-biotinyl-6-aminocaproate, characterised in that said method includes a step of activating N-biotinyl-6-aminocaproic acid in the form of a mixed anhydride, followed by coupling said mixed anhydride with N-hydroxysuccinimide.

## Claims

### Claim 1

A process for preparing N-succinimidyl N-biotinyl-6-amino caproate corresponding to formula (I) and comprising an activated ester function:
said process comprising a stage of activating, in the form of a mixed anhydride, the acid function of the compound (II):
so as to obtain the compound (II′), in which R represents an alkyl or aryl group:
followed by coupling of the compound (II′) with N-hydroxysuccinimide.

### Claim 2 (depends on 1)

The process as claimed in claim 1, wherein the activation of the acid function of the compound (II) is carried out by treating said compound with an alkyl or aryl haloformate of formula X′COOR, where R represents an alkyl or aryl group and X′ represents a halogen atom, in the presence of a weak base of tertiary amine type, in a polar and aprotic solvent.

### Claim 3 (depends on 2)

The process as claimed in claim 2, wherein said haloformate of formula X′COOR is ethyl chloroformate.

### Claim 4 (depends on 2)

The process as claimed in claim 2, wherein said weak base of tertiary amine type is triethylamine.

### Claim 5 (depends on 2)

The process as claimed in claim 2, wherein said polar and aprotic solvent is selected from dimethylformamide, dimethyl sulfoxide or N-methylpyrrolidone.

### Claim 6 (depends on 1)

The process as claimed in claim 1, wherein the stage of activating the acid function of the compound (II) is carried out at a temperature below 0° C.

### Claim 7 (depends on 1)

The process as claimed in claim 1, wherein the compound (II) is obtained by means of a step of activating, in the form of an ester, the acid function of the compound (III):
so as to obtain the compound (III′):
followed by coupling of the compound (III′) with aminocaproic acid.

### Claim 8 (depends on 7)

The process as claimed in claim 7, wherein the activation of the acid function of the compound (III) is carried out using a haloacetonitrile, in the presence of a weak base of tertiary amine type, in a polar and aprotic solvent.

### Claim 9 (depends on 8)

The process as claimed in claim 8, wherein said haloacetonitrile is chloroacetonitrile.

### Claim 10 (depends on 8)

The process as claimed in claim 8, wherein said weak base of tertiary amine type is triethylamine.

### Claim 11 (depends on 8)

The process as claimed in claim 8, wherein said polar and aprotic solvent is selected from dimethylformamide, dimethyl sulfoxide or N-methylpyrrolidone.

### Claim 12 (depends on 7)

The process as claimed in claim 7, wherein the reaction for activation of the acid function of the compound (III) is carried out at approximately 60° C.

### Claim 13 (depends on 7)

The process as claimed in claim 7, wherein the coupling reaction between the compound (III′) and aminocaproic acid is carried out at approximately 100° C.

### Claim 14 (depends on 1)

A process for preparing biotinylated polysaccharides, comprising the following stages:
preparing the compound (I) according to the process defined in claim 1, then
coupling the compound (I) with a polysaccharide which has a function that is reactive toward the activated ester function of the compound (I).

### Claim 15 (depends on 14)

The process as claimed in claim 14, wherein said reactive function of the polysaccharide is an amine function.

### Claim 16 (depends on 1, 14)

The process as claimed in claim 14, wherein it consists of the preparation of idrabiotaparinux and comprises the following stages:
preparing the compound (I) according to the process defined in claim 1, then
coupling the compound (I) with the sodium salt of the pentasaccharide methyl (2-amino-2-deoxy-3,4-di-O-methyl-6-O-sulfonato-α-D-glucopyranosyl)-(1→4)-(2,3-di-O-methyl-β-D-glucopyranosyluronic acid)-(1→4)-(2,3,6-tri-O-sulfonato-α-D-glucopyranosyl)-(1→4)-(2,3-di-O-methyl-α-L-idopyranosyluronic acid)-(1→4)-2,3,6-tri-O-sulfonato-α-D-glucopyranoside.
